These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

120 related articles for article (PubMed ID: 8667183)

  • 1. Comparative clinical pharmacology of short-acting mu opioids in drug abusers.
    Greenwald MK; June HL; Stitzer ML; Marco AP
    J Pharmacol Exp Ther; 1996 Jun; 277(3):1228-36. PubMed ID: 8667183
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Studies on the abstinence-like overshoot following reversal of the potent 19-isoamyl derivative of etorphine with naloxone. A comparison with the opioids fentanyl and alfentanil.
    Freye E; Neruda B; Smith OW
    Arzneimittelforschung; 1997 Jan; 47(1):6-9. PubMed ID: 9037435
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Antinociceptive and respiratory effects of nalbuphine in rhesus monkeys.
    Gerak LR; Butelman ER; Woods JH; France CP
    J Pharmacol Exp Ther; 1994 Nov; 271(2):993-9. PubMed ID: 7965822
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Human pharmacology of the opioid neuropeptide dynorphin A(1-13).
    Greenwald MK; Stitzer ML; Haberny KA
    J Pharmacol Exp Ther; 1997 Jun; 281(3):1154-63. PubMed ID: 9190848
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Hemodynamic effects of GI 87084B, an ultra-short acting mu-opioid analgesic, in anesthetized dogs.
    James MK; Vuong A; Grizzle MK; Schuster SV; Shaffer JE
    J Pharmacol Exp Ther; 1992 Oct; 263(1):84-91. PubMed ID: 1403806
    [TBL] [Abstract][Full Text] [Related]  

  • 6. A comparison of alfentanil and fentanyl in short operations with special reference to their duration of action and postoperative respiratory depression.
    van Leeuwen L; Deen L; Helmers JH
    Anaesthesist; 1981 Aug; 30(8):397-9. PubMed ID: 6116461
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Pharmacology of epidural fentanyl, alfentanil, and sufentanil in volunteers.
    Coda BA; Brown MC; Schaffer R; Donaldson G; Jacobson R; Hautman B; Shen DD
    Anesthesiology; 1994 Nov; 81(5):1149-61. PubMed ID: 7978473
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Pharmacokinetic-pharmacodynamic modeling of the electroencephalogram effect of synthetic opioids in the rat: correlation with the interaction at the mu-opioid receptor.
    Cox EH; Kerbusch T; Van der Graaf PH; Danhof M
    J Pharmacol Exp Ther; 1998 Mar; 284(3):1095-103. PubMed ID: 9495871
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Reinforcing effect of alfentanil is mediated by mu opioid receptors: apparent pA2 analysis.
    Bertalmio AJ; Woods JH
    J Pharmacol Exp Ther; 1989 Nov; 251(2):455-60. PubMed ID: 2553919
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Pharmacodynamics, pharmacokinetics, and clinical uses of fentanyl, sufentanil, and alfentanil.
    Willens JS; Myslinski NR
    Heart Lung; 1993; 22(3):239-51. PubMed ID: 8387987
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Opioids with different affinity for subreceptors induce different effects on early and late sensory evoked potentials (SEP) in man.
    Freye E; Buhl R; Ciaramelli F
    NIDA Res Monogr; 1986; 75():551-4. PubMed ID: 2829001
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Post-anesthesia recovery after infusion of propofol with remifentanil or alfentanil or fentanyl in morbidly obese patients.
    Gaszynski TM; Strzelczyk JM; Gaszynski WP
    Obes Surg; 2004 Apr; 14(4):498-503; discussion 504. PubMed ID: 15130225
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Enhancement of analgesia from systemic opioid in humans by spinal cholinesterase inhibition.
    Hood DD; Mallak KA; James RL; Tuttle R; Eisenach JC
    J Pharmacol Exp Ther; 1997 Jul; 282(1):86-92. PubMed ID: 9223543
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Relative potency of levo-alpha-acetylmethadol and methadone in humans under acute dosing conditions.
    Eissenberg T; Stitzer ML; Bigelow GE; Buchhalter AR; Walsh SL
    J Pharmacol Exp Ther; 1999 May; 289(2):936-45. PubMed ID: 10215673
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [The opioid tramadol demonstrates excitatory properties of non-opioid character--a preclinical study using alfentanil as a comparison].
    Freye E; Latasch L; Von Bredow G; Neruda B
    Schmerz; 1998 Feb; 12(1):19-24. PubMed ID: 12799988
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Ventilatory effects during and after continuous infusion of fentanyl or alfentanil.
    Andrews CJ; Sinclair M; Prys-Roberts C; Dye A
    Br J Anaesth; 1983; 55 Suppl 2():211S-216S. PubMed ID: 6418195
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Discriminative stimulus effects of opioids in pigeons trained to discriminate fentanyl, bremazocine and water: evidence of pharmacological selectivity.
    Picker MJ; Cook CD
    Behav Pharmacol; 1997 Jun; 8(2-3):160-73. PubMed ID: 9833011
    [TBL] [Abstract][Full Text] [Related]  

  • 18. DPI-3290 [(+)-3-((alpha-R)-alpha-((2S,5R)-4-Allyl-2,5-dimethyl-1-piperazinyl)-3-hydroxybenzyl)-N-(3-fluorophenyl)-N-methylbenzamide]. II. A mixed opioid agonist with potent antinociceptive activity and limited effects on respiratory function.
    Gengo PJ; Pettit HO; O'Neill SJ; Su YF; McNutt R; Chang KJ
    J Pharmacol Exp Ther; 2003 Dec; 307(3):1227-33. PubMed ID: 14534367
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Mu-opioid self-administration vs passive administration in heroin abusers produces differential EEG activation.
    Greenwald MK; Roehrs TA
    Neuropsychopharmacology; 2005 Jan; 30(1):212-21. PubMed ID: 15508021
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Buprenorphine, morphine and naloxone effects during ascending morphine maintenance in humans.
    Schuh KJ; Walsh SL; Bigelow GE; Preston KL; Stitzer ML
    J Pharmacol Exp Ther; 1996 Aug; 278(2):836-46. PubMed ID: 8768738
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.